U.S. flag

An official website of the United States government

NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > About Us > Center for Global Health Studies > Behavioral Economics in Global Health Print

Behavioral Economics in Global Health

Behavioral economics and conditional incentives have been used to strengthen healthcare engagement and health outcomes by providing small incentives or “nudges” to encourage certain health behaviors, such as attending routine clinic appointments, adherence to medication, and vaccine uptake. Although a growing body of research evidence indicates that these strategies can be impactful when done well, adoption of these approaches in real-world health programs remains limited.

The Center for Global Health Studies is interested in exploring the state of the science and practice of behavioral economics, with the aim of understanding how to best strengthen its impact and promote its effective use in health programming. To date, CGHS has co-hosted a satellite session at the 24th annual International AIDS Society Conference. CGHS will continue to work with interested NIH Institutes and Centers to explore ways to support the science of behavioral economics to improve global health.

2022 Virtual Satellite for the 24th International AIDS Conference

Behavioral Economics and Conditional Incentives to Strengthen HIV Treatment and Prevention: Actioning the Science

CGHS and the National Institute of Mental Health’s Division of AIDS Research led a satellite session at the AIDS 2022 Conference to examine the use of behavioral economics and conditional incentives in HIV treatment and prevention programs. The intended audience for this satellite are researchers, implementers, and funders who are curious about behavioral economic and conditional incentives approaches. The satellite session opened with research scientists who reviewed core concepts in behavioral economics and contemporary forms of conditional economic incentives, as well as their mechanisms of action, and the evidence base for their impact in the HIV treatment and prevention continua. The symposium then highlighted examples of real-world HIV treatment and preventions program that currently integrate behavioral economic or conditional incentives into specialized clinics or routine services. It concluded with a multisectoral panel with community members, scientists, technologists, and high-level government and public health officials; this group discussed key directions for further research, implementation, and financing of behavioral economic and conditional incentives in HIV treatment and prevention delivery.


Session Outline

AgendaPanelists
Welcome and introduction of session agenda
  • Dianne Rausch, National Institute of Mental Health
  • Rachel Sturke, Fogarty International Center
What are conditional incentives and behavioral economic approaches? A review of key concepts
  • Harsha Thirumurthy, University of Pennsylvania
What is the current evidence for the impact of conditional incentives and behavioral economic approaches in HIV care and prevention?
  • Sandra McCoy, University of California, Berkeley
Example of HIV treatment and prevention programs that utilize incentives and behavioral economic approaches: Indlela
  • Sofie Pascoe, University of Witwatersrand
  • Candice Chetty-Makkan, University of Witwatersrand
Example of HIV treatment and prevention programs that utilize incentives and behavioral economic approaches: Seattle MAX clinic
  • Julie Dombrowski, University of Washington
Advancing the implementation and use of behavioral economic and incentives approaches: Stakeholder perspectives

Facilitated by:

  • Michael Stirratt, National Institute of Mental Health
  • Susan Vorkoper, Fogarty International Center

Panelists:

  • Omar Galarraga, Brown University
  • Catherine Godfrey, PEPFAR
  • Sebastian Linnemayr, RAND Corporation
  • Natalino Mwenda, Rasello Inc.
  • Prosper Njau, Ministry of Health and Social Welfare, Tanzania
Conclusion with top-line themes and directions
  • Dianne Rausch, National Institute of Mental Health
  • Rachel Sturke, Fogarty International Center

Inquiries

Susan Vorkoper, M.P.H., M.S.W.
Global Health Research and Policy Analyst
Fogarty Division of International Science Policy, Planning and Evaluation
Email: Susan.Vorkoper@nih.gov

Updated July 27, 2022